DRX DLY S&P Biotech Bull 3XETF
13F holders, Q2 2026 (June 30)4holders
0new positions
0sold out
$289.58avg. 13F price*
At the end of Q2 2026, 4 institutions reported holding DRX DLY S&P Biotech Bull 3X in their 13F filings, unchanged from Q1 2026. 0 opened new positions and 0 sold out. The largest holders were Parallel Advisors, LLC ($146K), Cornerstone Planning Group LLC ($9K) and Hollencrest Capital Management ($8K).
- Company
- DRX DLY S&P Biotech Bull 3X
- Filed as
- DIREXION DAILY S&P BIOTECH BULL 3X ETF (Q2 2026)
- CUSIP
- 25490K323
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q1 2026 → Q2 2026
| Institutions | Total Value | |
|---|---|---|
| New Positions | 0 | $0 |
| Exits | 0 | $0 |
All 13F filers, Q1 2026 → Q2 2026: 75 shares sold, net −75 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 4 holders
| Parallel Advisors, LLC | 0.00% | No change | 500 | $146K |
| Cornerstone Planning Group LLC | 0.00% | No change | 36 | $9K |
| Hollencrest Capital Management | 0.00% | No change | 29 | $8K |
| EverSource Wealth Advisors, LLC | 0.00% | Reduce -88.2% | 10 | $3K |
"% of holder's portfolio" is DRX DLY S&P BIOTECH BULL 3X's weight in each manager's 13F, not the share of DRX DLY S&P Biotech Bull 3X the manager owns.